Insights

Stay abreast of key issues and critical thinking within the European rare disease community.

Pharmacovigilance and regulatory affairs: an introduction to drug safety monitoring and the role of outsourcing
The pharmaceutical supply chain: a breakdown of the key components
Launching pharmaceuticals in Belgium, the Netherlands, and Luxembourg: opportunities and challenges
Improving health equity in Europe’s small countries: how can we remove the barriers to access?
Launching pharmaceuticals in the Nordics: opportunities and challenges
Navigating market access in Sweden
ESG in pharma: meeting requirements in the Nordic region
The power of joint procurement: analysing cross-border initiatives in Benelux and the Nordics
Rare Disease Day: why raising awareness is essential for a fairer future
How early planning leads to successful market access and drug launches in Europe

Press Room

Discover the latest corporate news from AMPS, along with press releases and company announcements.